Complex Congenital Heart Diseases and Pregnancy: Maternal and Fetal Risks
Abstract Background: The improvement in surgical techniques has contributed to an increasing number of childbearing women with complex congenital heart disease (CCC). However, adequate counseling about pregnancy in this situation is uncertain, due to a wide variety of residual cardiac lesions. Objectives: To evaluate fetal and maternal outcomes in pregnant women with CCC and to analyze the predictive variables of prognosis. Methods: During 10 years we followed 435 consecutive pregnancies in patients (pts) with congenital heart disease. Among of them, we selected 42 pregnancies in 40 (mean age of 25.5 ± 4.5 years) pts with CCC, who had been advised against pregnancy. The distribution of underlying cardiac lesions were: D-Transposition of the great arteries, pulmonary atresia, tricuspid atresia, single ventricle, double-outlet ventricle and truncus arteriosus. The surgical procedures performed be fore gestation were: Fontan, Jatene, Rastelli, Senning, Mustard and other surgical techniques, including Blalock, Taussing, and Glenn. Eight (20,0%) pts did not have previous surgery. Nineteen 19 (47.5%) pts had hypoxemia. The clinical follow-up protocol included oxygen saturation recording, hemoglo bin and hematocrit values; medication adjustment to pregnancy, anticoagulation use, when necessary, and hospitalization from 28 weeks, in severe cases. The statistical significance level considered was p
Publication date: Available online 21 September 2020Source: Academic RadiologyAuthor(s): Yu Wang, Li Qun Jia, Yan Xiu Hu, Yue Xin, Xi Yang, Xiao Man Wang
Publication date: Available online 21 September 2020Source: Pregnancy HypertensionAuthor(s): Kim J.C. Verschueren, Rubinah R. Paidin, Annabel Broekhuis, Olivier S.S. Ramkhelawan, Lachmi R. Kodan, Humphrey H.H. Kanhai, Joyce L. Browne, Kitty W.M. Bloemenkamp, Marcus J. Rijken
Publication date: Available online 22 September 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Otto Mayer, Jan Bruthans, Jitka Seidlerová, Petra Karnosová, Markéta Mateřánková, Julius Gelžinský, Martina Rychecká, Jan Opatrný, Peter Wohlfahrt, Radek Kučera, Ladislav Trefil, Renata Cífková, Jan Filipovský, Cees Vermeer
SUPPLEMENTS could be used to improve the health of your heart, as well as to protect against high cholesterol symptoms and signs. Add these cheap capsules to your diet to lower your risk of heart disease. Should you consider speaking to a doctor about your cholesterol?
Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Ramón Villaverde-González, Antonio Candeliere-Merlicco, María Aránzazu Alonso-Frías, Eladio Aparicio Castro, Andrés Carrillo Alcaraz, Javier Mallada Frechín, Ángel Pérez Sempere
Today, approximately 20% of the U.S. population — about 60 million people — live in rural areas, which make up 97% of the land area in the United States. People living in rural America have less access to health care and are more likely than residents of urban areas to die from chronic conditions such as heart disease, cancer, stroke, and chronic lower respiratory disease. Moreover, long-standing systemic health and social inequities have put many rural residents at increased risk of getting COVID-19. The rural/urban inequities in health and health care warrant more rigorous and innovative scientific research t...
Authors: Wang R, Gao C, Kawashima H, Modolo R, Rosseel L, Onuma Y, Soliman O, Serruys PW, Mylotte D Abstract Valvular heart disease (VHD) remains a major societal and economic burden worldwide. Percutaneous valve technologies have revolutionized the treatment of VHD and emerged as an alternative treatment option in elderly patients at all levels of surgical risk. In 2019 and 2020, various new and improved transcutaneous treatment technologies for the treatment of VHD have emerged, as well as some important landmark trials were published. In this review, we present the most recent and relevant studies that emerged o...
[The Point] Having registered series of maternal deaths in The Gambia, a group of concern Gambians called Mbama Care Foundation in partnership with Gambian Women's Lives Matter will hold a peaceful protest today 23 September 2020 at Westfield.
CONCLUSIONS: Pregnancy PFAS were associated with greater gestational weight gain, weight retention, and weight gain years after pregnancy. PMID: 32959518 [PubMed - in process]
Condition: To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women Interventions: Drug: sublingual Misoprostol; Drug: Intrauterine Misoprostol Sponsor: Rajavithi Hospital Not yet recruiting